Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big Pharma Exit: Who's Fighting the Superbugs?
CNBC
Tuesday, April 23, 2013 - 10:43am
tags:
superbugs, GSK, Pfizer, AstraZeneca, Merck
AstraZeneca Faces "Tremendous Operational Challenges"
Motley Fool
Tuesday, April 23, 2013 - 10:42am
tags:
Pascal Soriot, AstraZeneca
Bristol-Myers Hepatitis C Combo Therapy Blunts Disease
Bloomberg
Tuesday, April 23, 2013 - 8:48am
tags:
BMS-791325, Bristol-Myers Squibb, hepatitis C, daclatasvir, asunaprevir
Roche to shed 170 jobs in diagnostics restructuring
Reuters
Tuesday, April 23, 2013 - 8:47am
tags:
diagnostics, Roche, restructuring
Merck's Experimental Hepatitis C Drug Beats Victrelis
Bloomberg
Tuesday, April 23, 2013 - 8:42am
tags:
Victrelis, hepatitis C, Merck, MK-5172
Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients
Bloomberg
Tuesday, April 23, 2013 - 7:57am
tags:
hepatitis C, Achillion, ACH-3102
[video]No ‘Silver Bullet’ for Making Health Care Cheaper: J&J CEO
CNBC
Tuesday, April 23, 2013 - 7:56am
tags:
JNJ, healthcare reform, recalls, earnings, Alex Gorsky, Pharma CEOs
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
Tuesday, April 23, 2013 - 7:54am
tags:
Eli Lily, diabetes, insulin, LY2605541, dulaglutide, LY2963016, empagliflozin
Moody's sees pick-up in pharmaceutical industry M&A in 2013
Reuters
Tuesday, April 23, 2013 - 7:52am
tags:
M&A, Roche, Pfizer, Novartis, AstraZeneca
AstraZeneca, Alchemia in multi-target drug discovery collaboration
Yahoo/Fly on the Wall
Tuesday, April 23, 2013 - 7:51am
tags:
AstraZeneca, Alchemia, R&D
AbbVie hepatitis C drugs knock out virus at 8 weeks
Reuters
Tuesday, April 23, 2013 - 7:50am
tags:
hepatitis C, AbbVie, ABT-450, ABT-333, ABT-267
Whisper Number Impact: Earnings Preview For Gilead Sciences
Seeking Alpha
Monday, April 22, 2013 - 2:07pm
tags:
Gilead, earnings
4 Stocks Pushing The Drugs Industry Downward
TheStreet.com
Monday, April 22, 2013 - 2:05pm
tags:
Valeant Pharmaceuticals, Vertex Pharmaceuticals, Alexion, Sanofi
Forbes Earnings Preview: GlaxoSmithKline
Forbes
Monday, April 22, 2013 - 1:59pm
tags:
earnings, GSK
Merck CEO snags 16% raise to $15.5M, in year of 'significant hurdles'
Fierce Pharma
Monday, April 22, 2013 - 11:56am
tags:
Merck, executive pay, Kenneth Frazier
Sanofi's Vaccine Gets EU Approval
Yahoo/Zacks
Monday, April 22, 2013 - 11:55am
tags:
Europe, Sanofi, vaccines, Hexyon, Hexacima
Delcath: A Cancer Treatment Biotech With Good Short And Long-Term Potential
Seeking Alpha
Monday, April 22, 2013 - 11:22am
tags:
Delcath, liver cancer
Top AstraZeneca investor backs Soriot and his 'golden hello'
Fierce Pharma
Monday, April 22, 2013 - 11:19am
tags:
Pascal Soriot, executive pay, AstraZeneca
Targacept moving forward with trials for schizophrenia treatment
Winston-Salem Journal, NC
Monday, April 22, 2013 - 11:16am
tags:
schizophrenia, Targacept, TC-5214
5 Must-Watch Earnings Reports in the Health-Care Sector This Week
Motley Fool
Monday, April 22, 2013 - 11:14am
tags:
earnings, Eli Lilly, Wellpoint, Biogen Idec, Celgene, Alexion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.